BioCentury | Aug 6, 2020
Management Tracks
Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more
...Centrexion Therapeutics Corp. and served as chairman and CEO of Pfizer Inc. (NYSE:PFE) in 2006-10. Mission Therapeutics Ltd....
...Ltd. (NSE:GLENMARK; BSE:532296) and Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus...
...Ltd. (NSE:GLENMARK; BSE:532296) and Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus...